Investor Plans to Cash Out of Bayer with Major Stake Sale

A big player in Bayer’s stock is preparing to sell off a huge chunk of its shares, sparking curiosity about what this means for the company’s future. Reports show the investor intends to unload about 8. 5 million shares through JPMorgan Chase, a move that could bring in roughly 327 million euros bas